BRIEF published on 08/24/2026 at 18:47, 2 months 22 days ago Aliko Scientific: Financial Status and Outlook Convertible Bonds Financial Situation ALIKO SCIENTIFIC Outlook 2026 Oncological Diagnosis
PRESS RELEASE published on 08/24/2026 at 18:46, 2 months 22 days ago Inside Information: Other news releases ALIKO Scientific provides financial update post FY 2025 results publication, reaffirming business momentum. Details on auditors' reports, financial position, cash flow forecast, and convertible note financing Financial Update Convertible Note Financing Auditors' Reports ALIKO SCIENTIFIC FY 2025 Results
PRESS RELEASE published on 08/24/2026 at 18:42, 2 months 22 days ago Informations privilégiées: Autres communiqués Aliko Scientific publie des informations financières complémentaires suite à la publication de ses résultats annuels 2025, réaffirmant sa dynamique d'activité et sa situation financière renforcée Résultats Annuels Trésorerie Situation Financière ALIKO SCIENTIFIC Dynamique D'activité
BRIEF published on 07/30/2026 at 21:54, 3 months 15 days ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
BRIEF published on 07/30/2026 at 21:54, 3 months 15 days ago Ikonisys SA annonce des résultats annuels 2025 prometteurs Résultats Financiers Croissance Ikonisys Diagnostic Oncologique ALIKO SCIENTIFIC
BRIEF published on 07/30/2026 at 21:54, 3 months 15 days ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 3 months 15 days ago Ikonisys SA annonce une augmentation de son chiffre d'affaires et des développements en 2025 Ikonisys SA Croissance Des Revenus Résultats Financiers 2025 Diagnostic En Oncologie Aliko Scientifique
PRESS RELEASE published on 07/30/2026 at 21:49, 3 months 15 days ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
PRESS RELEASE published on 07/30/2026 at 21:49, 3 months 15 days ago Informations privilégiées / Communiqué sur comptes, résultats Ikonisys SA publie ses résultats financiers annuels 2025. Amélioration de 32,9% de l'EBITDA à -1,14 M€. Développement de la plateforme oncologique avec brevet ACTA, Urine24 et accord Menarini Diagnostics Résultats Financiers EBITDA Ikonisys SA Développements Plateforme Oncologique
BRIEF published on 07/23/2026 at 07:35, 3 months 23 days ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
Published on 11/14/2026 at 12:56, 1 day 6 hours ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 17 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 18 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 18 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 19 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 19 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 21 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 2 days ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 2 days ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 2 days 7 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 2 days 7 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 2 days 11 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 19 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
